Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemoradiation as primary management of esophageal cancer.

× No keyword cloud information.

10 in total

1. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Authors: Yosuke Kumekawa; Kazuhiro Kaneko; Hiroaki Ito; Toshinori Kurahashi; Kazuo Konishi; Atsushi Katagiri; Taikan Yamamoto; Meiko Kuwahara; Yutaro Kubota; Takashi Muramoto; Yoshihide Mizutani; Michio Imawari
Journal: J Gastroenterol Date: 2006-05 Impact factor: 7.527

2. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy.

Authors: Fumiko Sunada; Masayuki Itabashi; Hisanao Ohkura; Toshiyuki Okumura
Journal: World J Gastroenterol Date: 2005-09-28 Impact factor: 5.742

3. Two cases of carcinoma of the cervical esophagus adjacent to the larynx treated with surgery.

Authors: Kiyoaki Tsukahara; Kazuyoshi Kawabata
Journal: Int J Clin Oncol Date: 2009-08-25 Impact factor: 3.402

4. Outcomes of patients with stage IVA esophageal cancer (Japanese classification) treated with definitive chemoradiotherapy.

Authors: Akira Anbai; Makoto Koga; Satoru Motoyama; Mario Jin; Hiroyuki Shibata; Manabu Hashimoto
Journal: Jpn J Radiol Date: 2013-02-02 Impact factor: 2.374

5. Downstaging of esophageal cancer after preoperative radiation and chemotherapy.

Authors: S B Vogel; W M Mendenhall; M D Sombeck; R Marsh; E R Woodward
Journal: Ann Surg Date: 1995-06 Impact factor: 12.969

6. NSE can predict the sensitivity to definitive chemoradiotherapy of small cell carcinoma of esophagus.

Authors: Hongjiang Yan; Renben Wang; Shumei Jiang; Kunli Zhu; Rui Feng; Xiaoqing Xu; Xiangjiao Meng
Journal: Med Oncol Date: 2013-12-05 Impact factor: 3.064

7. Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer.

Authors: Mari Kogo; Ayako Suzuki; Kazuhiro Kaneko; Keiichiro Yoneyama; Michio Imawari; Yuji Kiuchi
Journal: Dig Dis Sci Date: 2008-02-08 Impact factor: 3.199

8. Definitive chemoradiotherapy with capecitabine and cisplatin in patients with esophageal cancer: a pilot study.

Authors: Soo Jung Lee; Byung Min Ahn; Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Joon Ho Moon; Eung Bae Lee; Jae Chul Kim; In Kyu Park; Seong Woo Jeon
Journal: J Korean Med Sci Date: 2009-02-28 Impact factor: 2.153

9. Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer.

Authors: S Petrasch; A Welt; A Reinacher; U Graeven; M König; W Schmiegel
Journal: Br J Cancer Date: 1998-08 Impact factor: 7.640

10. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus.

Authors: K Kaneko; H Ito; K Konishi; T Kurahashi; T Ito; A Katagiri; T Yamamoto; T Kitahara; Y Mizutani; A Ohtsu; K Mitamura
Journal: Br J Cancer Date: 2003-01-13 Impact factor: 7.640

10 in total